Skip to main content
Skip to main content
ADMT logo

ADM Tronics Unlimited, Inc. (ADMT) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.05 +$0.01 (+25.00%) |CouncilSplit View · 51 · B
MCap: $3.38M| Vol: 19K| 52-wk range: $0.02 – $0.12

Market cap $3.38M is the value of all shares combined. Beta 0.23: the stock has moved about 77% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

ADM Tronics Unlimited, Inc. (ADMT) trades at $0.05. ADM Tronics Unlimited, Inc. develops, manufactures, and sells electronics, chemicals, and engineered products, primarily for medical applications. Market cap: $3.38M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026
ADM Tronics Unlimited, Inc. develops, manufactures, and sells electronics, chemicals, and engineered products, primarily for medical applications. The company operates through three segments: Electronics, Chemical, and Engineering, serving diverse markets including healthcare and cosmetics.

Analyst Coverage for ADMT: ADMT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ADMT against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the ADMT film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Split View 51/100 · B

ADMT: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Overvalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

ADM Tronics Unlimited, Inc. (ADMT) Healthcare & Pipeline Overview

CEOAndre' DiMino
Employees30
HeadquartersNorthvale, US
IPO Year1990

ADM Tronics Unlimited, Inc. develops and manufactures electronics for non-invasive medical applications and specialty chemicals. Operating in the healthcare sector, the company offers devices for diagnostics and therapeutics, alongside chemical products for medical and cosmetic uses, serving markets across the United States, Asia, Australia, and Europe.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for ADMT?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

ADM Tronics Unlimited, Inc. presents a unique investment proposition within the medical devices and specialty chemicals sectors. The company's diverse product portfolio, spanning electronics, chemicals, and engineering services, offers multiple revenue streams. With a market capitalization of $3.38M and a negative P/E ratio of -900.65, the company's valuation reflects current challenges, indicated by a negative profit margin of -0.2%. However, a gross margin of 38.6% suggests potential for improved profitability. Growth catalysts include expansion of its medical device offerings and increased demand for its specialty chemical products. Key risks include its OTC market listing and limited financial disclosure.

Based on FMP financials and quantitative analysis

ADMT Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $3.38M indicates a micro-cap company with potential for high growth but also higher risk.

  • Negative P/E ratio of -900.65 reflects current unprofitability, requiring further investigation into the underlying causes and potential turnaround strategies.
  • Gross margin of 38.6% demonstrates the company's ability to generate revenue above the cost of goods sold, suggesting efficiency in production.
  • Beta of 0.23 indicates low volatility compared to the market, which may appeal to risk-averse investors.
  • The company operates in the Electronics, Chemical, and Engineering segments, diversifying its revenue streams and reducing dependence on a single product or market.

Who Are ADMT's Competitors?

ADMT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
GBCS Selectis Health, Inc. $5.74 0.00% $17.6M
RDGL Vivos Inc. $0.05 0.00% $23.9M 619-signal
SNWV SANUWAVE Health, Inc. $4.00 -0.99% $34.4M 365-pillar
HYPD Hyperion DeFi, Inc. $3.59 -2.18% $54.4M 365-pillar
LNSR LENSAR, Inc. $7.74 -3.85% $95.1M 485-pillar
APYX Apyx Medical Corporation $2.89 -5.25% $122M 365-pillar
JMDMF Japan Medical Dynamic Marketing, Inc. $5.00 0.00% $132M 499-signal
INGN Inogen, Inc. $5.18 -1.71% $140M 365-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are ADMT's Key Strengths?

Diverse product portfolio across electronics, chemicals, and engineering.

  • Proprietary technology in medical devices and chemical formulations.
  • Long-standing experience in the medical and chemical industries.
  • Established customer relationships in various markets.

What Are ADMT's Weaknesses?

Small market capitalization and limited financial resources.

  • Negative profitability and low revenue growth.
  • Dependence on OTC market listing.
  • Limited geographic diversification.

What Could Drive ADMT Stock Higher?

Potential FDA approval for new medical devices could drive revenue growth.

  • Expansion of distribution channels in Asia and Europe may increase market reach.
  • Increased demand for specialty chemical products due to environmental regulations.
  • Strategic partnerships with healthcare providers could enhance market penetration.

What Are the Key Risks for ADMT?

Financial-distress signal — its Altman Z-Score of -20.80 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-0.8%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from larger and more established companies.
  • Stringent regulatory requirements and potential product liability claims.
  • Economic downturns and fluctuations in demand.
  • Technological obsolescence and changing customer preferences.
  • Risks associated with OTC market listing, including limited liquidity and disclosure.

What Are the Growth Opportunities for ADMT?

  • Expansion of Medical Device Offerings: ADM Tronics can capitalize on the growing demand for non-invasive medical devices by expanding its product portfolio and targeting new therapeutic areas. The global medical device market is projected to reach $600 billion by 2028, offering significant growth potential. By investing in research and development and obtaining regulatory approvals for new devices, ADM Tronics can increase its market share and revenue.
  • Increased Demand for Specialty Chemical Products: The company can leverage the increasing demand for water-based primers, adhesives, coatings, and resins in various industries, including healthcare and cosmetics. The global specialty chemicals market is expected to reach $900 billion by 2027, driven by stringent environmental regulations and demand for sustainable solutions. ADM Tronics can focus on developing innovative and environmentally friendly chemical products to capture a larger share of this market.
  • Geographic Expansion: ADM Tronics can expand its operations into new geographic markets, particularly in Asia and Europe, where demand for medical devices and specialty chemicals is growing rapidly. By establishing partnerships with local distributors and obtaining necessary regulatory approvals, the company can increase its global presence and revenue streams. This expansion should be strategic and phased, focusing on markets with favorable regulatory environments and growth potential.
  • Strategic Acquisitions: ADM Tronics can pursue strategic acquisitions of complementary businesses to expand its product portfolio, market reach, and technological capabilities. By acquiring companies with innovative technologies or established customer bases, ADM Tronics can accelerate its growth and enhance its competitive position. These acquisitions should be carefully evaluated to ensure they align with the company's strategic objectives and financial capabilities.
  • Enhanced Research and Development: ADM Tronics can invest in enhanced research and development activities to develop innovative products and technologies that address unmet needs in the medical devices and specialty chemicals markets. By collaborating with universities and research institutions, the company can accelerate its innovation pipeline and gain a competitive edge. This includes focusing on cutting-edge technologies like biocompatible materials and advanced diagnostic tools.

What Are ADMT's Competitive Advantages?

  • Proprietary Technology: ADM Tronics owns proprietary technology in medical electronic therapeutic devices.
  • Specialized Chemical Formulations: The company has expertise in developing specialized water-based chemical formulations.
  • Regulatory Expertise: ADM Tronics possesses experience in navigating regulatory approval processes for medical devices.
  • Long-standing Customer Relationships: The company has established long-term relationships with customers in various industries.

What Does ADMT Do?

ADM Tronics Unlimited, Inc., founded in 1969 and headquartered in Northvale, New Jersey, operates as a developer, manufacturer, and seller of electronics, chemicals, and engineered products. The company's primary focus is on non-invasive medical applications, serving markets in the United States, Australia, Asia, and Europe. ADM Tronics operates through three segments: Electronics, Chemical, and Engineering. The Electronics segment offers proprietary devices used in diagnostics and therapeutics for both humans and animals, as well as electronic controllers for spas and hot tubs. The Chemical segment provides water-based primers, adhesives, coatings, resins, and chemical additives, including anti-static conductive paints and coatings. The Engineering segment focuses on research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies, including medical electronic therapeutic technology. Additionally, the company provides water-based adhesive and related topical formulations for maxillofacial prosthetic medical applications and professional makeup applications for film, TV, and theatrical productions.

What Products and Services Does ADMT Offer?

  • Develops and manufactures electronic devices for non-invasive medical applications.
  • Produces water-based primers, adhesives, coatings, and resins.
  • Offers chemical additives and anti-static conductive paints.
  • Provides research, development, and engineering services for medical devices and electronics.
  • Creates water-based adhesive formulations for maxillofacial prosthetic medical applications.
  • Develops formulations for professional makeup applications in film, TV, and theater.

How Does ADMT Make Money?

  • Sales of proprietary electronic devices for medical diagnostics and therapeutics.
  • Revenue from the sale of specialty chemical products to various industries.
  • Service fees for research, development, and engineering services.
  • Licensing of medical electronic therapeutic technology.

What Industry Does ADMT Operate In?

ADM Tronics Unlimited, Inc. operates within the medical devices and specialty chemicals industries. The medical devices industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand for non-invasive diagnostic and therapeutic solutions. The specialty chemicals industry is driven by demand for advanced materials and formulations across various applications, including healthcare and cosmetics. ADM Tronics' competitive landscape includes companies such as BIXT, BZYR, CVSI, DHBUF, and GBCS. The company's ability to navigate regulatory hurdles and develop innovative products will be crucial for success in these competitive markets.

Who Are ADMT's Key Customers?

  • Hospitals and clinics using medical diagnostic and therapeutic devices.
  • Spas and hot tub manufacturers using electronic controllers.
  • Manufacturers using water-based primers, adhesives, and coatings.
  • Film, TV, and theatrical productions using makeup formulations.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 23 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 45
2026-08-26 45
2026-08-29 45
2026-09-01 45
2026-09-04 45
2026-09-07 45
2026-09-10 45

What changed?

The score has stayed at 45.

Over the same 18 days the stock moved +0.0%.

Company Profile

ADM Tronics Unlimited, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Northvale, US. The company is led by CEO Andre' DiMino. ADMT has traded publicly since 1990.

ADM Tronics Unlimited, Inc. Financial Trajectory

ADM Tronics Unlimited, Inc. (ADMT) reported $866K in revenue for Q1 FY2027, reflecting 26.9% growth compared to the prior quarter. The company recorded net income of $32K, with diluted EPS of $0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, ADMT averaged $-0.00 in diluted EPS.

How ADM Tronics Unlimited, Inc. Is Valued

ADM Tronics Unlimited, Inc. carries a market capitalization of $3.38M, placing it in the micro-cap category.

ROE -1%

Key Financial Metrics

Return on equity for ADM Tronics Unlimited, Inc. stands at -0.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 9.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.14 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9

Financial Health

ADM Tronics Unlimited, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -20.80 places it in the distress zone, a signal of elevated financial risk.

ADMT Financials

Fundamental Snapshot

Revenue Growth (FY)
+4.7%
Net Income Growth (FY)
+18.4%
EPS Growth (FY)
+16.7%
Return on Equity (TTM)
-0.8%
Current Ratio
1.1
EV/EBITDA (TTM)
34.7

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • Diverse product portfolio across electronics, chemicals, and engineering.
  • Proprietary technology in medical devices and chemical formulations.
  • Long-standing experience in the medical and chemical industries.
  • Established customer relationships in various markets.

Bear Case

  • Small market capitalization and limited financial resources.
  • Negative profitability and low revenue growth.
  • Dependence on OTC market listing.
  • Limited geographic diversification.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 FY2027 $866,255 $32,363 $0.0005
Q4 FY2026 $682,821 -$198,480 -$0.0029
Q3 FY2026 $803,088 -$114,856 -$0.0017
Q2 FY2026 $887,498 -$114,672 -$0.0017

Q1 FY2027 · filed 19 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

ADMT Latest News

ADMT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ADMT.

Price Targets

Wall Street price target analysis for ADMT.

ADMT MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ADMT; grades run from A+ (80-100) to F (below 30).

Leadership: Andre' DiMino

CEO

Andre' DiMino serves as the CEO of ADM Tronics Unlimited, Inc. His background includes extensive experience in managing and growing technology-focused companies. He has been instrumental in guiding ADM Tronics through various stages of development, focusing on innovation and strategic partnerships. His expertise spans across electronics, chemicals, and engineering, enabling him to effectively lead the company's diverse operations. He oversees a team of 30 employees, driving the company's vision and strategic initiatives.

Track Record: Under Andre' DiMino's leadership, ADM Tronics has focused on expanding its product portfolio and market reach. Key achievements include the development of proprietary medical devices and the establishment of strategic partnerships. He has also overseen the company's efforts to navigate regulatory approvals and maintain compliance. His strategic decisions have been aimed at driving long-term growth and enhancing shareholder value.

ADMT OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that ADM Tronics Unlimited, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and less scrutiny, potentially leading to greater information asymmetry and volatility.

  • OTC Tier: OTC Other
Liquidity: As an OTC-listed stock, ADM Tronics may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of potential illiquidity and the impact on transaction costs. The limited liquidity can also amplify price volatility, increasing the risk of significant price swings.
OTC Risk Factors:
  • Limited Financial Disclosure: The lack of readily available financial information increases the difficulty of assessing the company's financial health and performance.
  • Lower Liquidity: Reduced trading volumes and wider bid-ask spreads can make it challenging to execute trades efficiently.
  • Higher Volatility: OTC stocks are generally more volatile than exchange-listed stocks, increasing the risk of significant price fluctuations.
  • Potential for Fraud: The lower regulatory oversight of the OTC market increases the risk of fraudulent activities and scams.
  • Limited Investor Protection: Investors in OTC stocks have less protection compared to those in exchange-listed stocks.
Due Diligence Checklist:
  • Verify the company's registration and regulatory filings.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • Long Operating History: The company has been in operation since 1969, suggesting a degree of stability and experience.
  • Diverse Product Portfolio: ADM Tronics offers a range of products and services across different segments.
  • Proprietary Technology: The company owns proprietary technology in medical devices and chemical formulations.
  • Established Customer Relationships: ADM Tronics has established relationships with customers in various industries.

ADMT Healthcare Stock FAQ

Is ADMT a good stock?

Stock Expert AI does not rate ADMT buy, sell or hold. ADM Tronics Unlimited, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about ADMT stock?

As of 2026-03-16, there is no readily available analyst coverage for ADMT stock due to its OTC listing and small market capitalization. Key valuation metrics include a negative P/E ratio of -900.65 and a gross margin of 38.6%.

What are the key factors to evaluate for ADMT?

Evaluate ADMT on fundamentals, analyst consensus, and risk factors. Key risks include its OTC market listing and limited financial disclosure. Not financial advice.

How frequently does ADMT data refresh on this page?

ADMT's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven ADMT's recent stock price performance?

ADM Tronics Unlimited, Inc. (ADMT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across electronics, chemicals, and engineering. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ADMT overvalued or undervalued right now?

ADM Tronics Unlimited, Inc. (ADMT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of ADMT?

Yes, most major brokerages offer fractional shares of ADM Tronics Unlimited, Inc. (ADMT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ADMT's earnings and financial reports?

ADM Tronics Unlimited, Inc. (ADMT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for ADMT earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available sources and may be subject to change.
  • OTC market data may be limited and less reliable than exchange-listed data.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover